News for Celsion Corporation (CLSN)

Published at

Jul 30, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Hepatic Tumor Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the Domain

Hepatic tumors are abnormal growth of liver cells on or in the liver. The Hepatic Tumor market is driven by several key factors reflecting the increasing...

MRNA.MX MRNA M1RN34.SA 0A45.L FUSN CHRS 115180.KQ CSPHF CLSN 0HUZ.L

Read more →
Published at

May 2, 2024 10:30 AM

by globenewswire.com

mixed

mixed

[Latest] Global Lipid Nanoparticles Market Size/Share Worth USD 1,899.8 Million by 2033 at a 14.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Gro

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Lipid Nanoparticles...

ZEG.DE WPLCF NSHSF NSHSD NSHS.CN JNJ HESG EQGPF DUL.DE DJNJ3.BA DJNJ2.BA CLSN AZNN.MX AZNCF AZN.L AZN ALNY ABBV34.SA ABBV.MX ABBV.BA ABBV A1LN34.SA 4AB.DE 0HUZ.L 0HD2.L 0A4J.L SLDB DCYHY DCYHF

Read more →
Published at

Jan 15, 2024 1:21 PM

by globenewswire.com

mixed

mixed

Liver Cancer Drugs Market Soaring Towards USD 2,332 Million by 2032 | CAGR of 9.3%

A primary driver for the growth of the liver cancer drugs market is the rising incidence of liver cancer globally. Factors contributing to this include the...

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE LLY.MX LLY.DE LLY.BA LLY LILY34.SA EXEL EX9.DE 0Q1G.L 0IJO.L ZEG.DE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA MRKD.BA MRK.SN MRK.PA MRK.MX MRK JNJ DJNJ3.BA DJNJ2.BA CLSN BRM.DE BMYB34.SA BMY.MX BMY.BA BMY AZNN.MX AZNCF AZN.L AZN AMGN.MX AMGN.BA AMGN AMG.DE ABBV34.SA ABBV.MX ABBV.BA ABBV 6MK.DE 4AB.DE 0K9E.L 0HUZ.L 0A4J.L ESALY ESALF 4523.T

Read more →
Published at

Sep 20, 2023 6:25 PM

by prnewswire.com

positive

positive

The Non-viral Transfection Reagents and Systems Market is projected to grow at ~10% CAGR till 2035, according to a market research report by Roots Analysis

/PRNewswire/ -- Roots Analysis has announced the addition of "Non-Viral Transfection Reagents and Systems Market, 2nd Edition, 2023-2035" report to its list of...

CLSN 0HUZ.L

Read more →
Published at

Jun 29, 2023 11:01 PM

by prnewswire.com

negative

negative

Liver Cancer Market to Proliferate Positively, Assesses DelveInsight | Key Companies Active in the Domain - SOTIO, GlaxoSmithKline, Pfizer, Merck, Takeda, Genentech, Boehringer Ingelheim, DNAtrix, Cel

/PRNewswire/ -- DelveInsight's Liver Cancer Market Insights report includes a comprehensive understanding of current treatment practices, liver cancer emerging...

FUSN CSPHF CLSN CHRS 115180.KQ 0HUZ.L

Read more →
Published at

Jun 13, 2023 7:00 PM

by globenewswire.com

negative

negative

Acute Lung Injury Market is Expected to Witness Upsurge in Growth, Assesses DelveInsight | Key Companies to Look Out - AstraZeneca, Asklepion, Reven, GEn1E, Organicell Regenerative Medicine, MediciNov

The dynamics of the acute lung injury market are anticipated to change in the coming years due to increased awareness of the complication, incremental...

VERU INCY I1NC34.SA CLSN 0J9P.L 0HUZ.L

Read more →
Published at

Jun 1, 2023 3:10 PM

by globenewswire.com

mixed

mixed

Atossa Appoints Life Sciences Financial and Operations Industry Veteran Greg Weaver as Chief Financial Officer

SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative...

ELOX ATAI PARD CLSN ATOS.MX ATOS 0HUZ.L

Read more →
Published at

Apr 6, 2023 7:15 PM

by prnewswire.com

neutral

neutral

Nucleic Acid Based Gene Therapy Global Market Report 2023: Major Players Include Celsion, Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics and Benitec Biopharma

/PRNewswire/ -- The

CLSN 0HUZ.L

Read more →
Published at

Mar 1, 2023 2:45 PM

by globenewswire.com

positive

positive

IMUNON CEO Issues Letter to Shareholders

Reviews 2022 accomplishments; sets forth 2023 milestones and long-term vision LAWRENCEVILLE, N.J., March 01, 2023 (GLOBE NEWSWIRE) -- IMUNON,...

MRNA CLSN AMGN

Read more →
Published at

Oct 20, 2022 8:28 AM

by etfdailynews.com

neutral

neutral

StockNews.com Initiates Coverage on Imunon (NASDAQ:CLSN)

Read StockNews.com Initiates Coverage on Imunon (NASDAQ:CLSN) at ETF Daily News

CLSN 0HUZ.L

Read more →
Published at

Oct 11, 2022 7:00 PM

by globenewswire.com

mixed

mixed

The Global Chemiluminescence Immunoassay Market to Grow at

The chemiluminescence immunoassay market is expected to grow due to factors such as rising disease prevalence, such as cancer, diabetes, and cardiovascular...

LLY.MX LLY.DE LLY.BA LLY LILY34.SA 300760.SZ 0Q1G.L 300832.SZ CLSN 0HUZ.L

Read more →
Published at

Sep 25, 2022 7:16 AM

by etfdailynews.com

positive

positive

Financial Survey: ImmunoCellular Therapeutics (OTCMKTS:IMUC) vs. Celsion (NASDAQ:CLSN)

Read Financial Survey: ImmunoCellular Therapeutics (OTCMKTS:IMUC) vs. Celsion (NASDAQ:CLSN) at ETF Daily News

IMUCW IMUC CLSN 0HUZ.L

Read more →
Published at

Jul 25, 2022 7:00 PM

by globenewswire.com

mixed

mixed

Liver Cancer Pipeline Insight | Clinical Trial Research Evaluation Report

DelveInsight’s liver cancer pipeline report depicts a robust space with 100+ active players working to develop 100+ pipeline therapies for liver cancer...

TKBIF PVCT 4974.T KNTPF BPMC AVEO 9939.HK 0HOJ.L CSPHF CLSN 600276.SS 115180.KQ 0HUZ.L

Read more →
Published at

May 29, 2022 7:24 PM

by etfdailynews.com

mixed

mixed

Analysts’ New Coverage for May 29th (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS)

Read Analysts’ New Coverage for May 29th (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) at ETF Daily News

XELB WVVI WNEB WHLM VTVT ULBI UBFO TTOO TTNP TSBK TRIB TREC TENX TEDU SYPR SVVC SUMR STRM SREV SOHO SNFCA SMMT SIEB SFE SBFG SAL RVSB RNWK RMTI RMCF RGLS RGCO RDI RAVE QUMU QUIK PWOD PWFL PULM PRPH PPBB PFIE PEBK PDEX PCTI PBPB OVLY OVBC OBCI NYMX NWFL NVCN NTWK NTIC NH NERV NEPT NAII MPX MCHX MBCN MACK LWAY LEDS LARK KTCC ITCB ITAUCORP.SN IRSA.BA IRS IRIX IPDN IHT IDRA HZN HWBK HLG HBP HALL GTIM GSIT GNCA GIGM GHM GENC GASS FWP FUNC FSFG FORD FNWB FENG FCCO FCAP FANH EVOK EVK ESSA EML EDUC EBMT DYNT DXYN DTEA DCTH CYD CYCC CVV CVLY CTHR CPIX CORR COE CNET CMCM CLSN CLRO CLRB CLIR CJJD CHNR CHMG CHCI CGIX CFMS CFFI CEMI CDTX CBFV CAAS BYFC BLPH BLCM BGSF BBGI AUTO ASUR ASTC ARL ARKR AP AMS ALOT ALIM AKTX AIRI AGFS AEZS AEY AEMD ACRX ACOR ABEO AAME AACG CGA CFRX

Read more →
Published at

May 21, 2022 7:44 PM

by etfdailynews.com

mixed

mixed

Investment Analysts’ New Coverage for May 21st (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS)

Read Investment Analysts’ New Coverage for May 21st (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) at ETF Daily News

XELB WVVI WNEB WHLM VTVT ULBI UBFO TTOO TTNP TSBK TRIB TREC TENX TEDU SYPR SVVC SUMR STRM SREV SOHO SNFCA SMMT SIEB SFE SBFG SAL RVSB RNWK RMTI RMCF RGLS RGCO RDI RAVE QUMU QUIK PWOD PWFL PULM PRPH PPBB PFIE PEBK PDEX PCTI PBPB OVLY OVBC OBCI NYMX NWFL NVCN NTWK NTIC NH NERV NEPT NAII MUX MPX MCHX MBCN MACK LWAY LEDS LARK KTCC ITCB ITAUCORP.SN IRSA.BA IRS IRIX IPDN IHT IDRA HZN HWBK HLG HBP HALL GTIM GSIT GNCA GIGM GHM GENC GASS FWP FUNC FSFG FORD FOE FNWB FENG FCCO FCAP FANH EVOK EVK ESSA EML EDUC EBMT DYNT DXYN DTEA DFFN DCTH CYD CYCC CVV CVLY CTHR CPIX CORR COE CNET CMCM CLSN CLRO CLRB CLIR CJJD CHNR CHMG CHCI CGIX CFMS CFFI CEMI CDTX CBFV CAAS BYFC BLPH BLCM BGSF BBGI AUTO ASUR ASTC ARL ARKR AP AMS ALOT ALIM AKTX AIRI AGFS AEZS AEY AEMD ACRX ACOR ABEO AAME AACG CGA CFRX

Read more →
Published at

May 20, 2022 4:52 PM

by globenewswire.com

mixed

mixed

Global Liposome Drug Delivery Market to Garner a Revenue of USD 11977.1 Million by 2031 and Grow with a CAGR of 10.69% During 2022-2031; Surge in Prevalence of Cancer to Drive Market Growth

Key Companies Covered in the Liposome Drug Delivery Market Research Report By Research Nester Are NIPPON FINE CHEMICAL CO., LTD., Sonic Biochem Extractions...

SPPI PRGON.MX PRGO.TA PRGO P1RG34.SA MACK 4362.T 0Y5E.L TKPHF TAKP34.SA TAKN.MX TAK CRDA.L COIHY COIHF ALPMY ALPMF 4503N.MX 4502.T 4502.S 0A87.L NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA JNJ GIS.DE GILDD.BA GILD.MX GILD DJNJ3.BA DJNJ2.BA CLSN 0K9E.L 0HUZ.L

Read more →
Published at

May 16, 2022 2:43 PM

by news.google.com

positive

positive

Celsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update

Celsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update - read this article along with other careers information, tips and advice on BioSpace

CLSN BIOQ 0HUZ.L

Read more →
Published at

May 16, 2022 2:00 PM

by globenewswire.com

positive

positive

Celsion Corporation Reports First Quarter 2022 Financial Results and Provides Business Update

DNA Mediated Immunotherapy and Next-Generation Vaccine Programs Supported with a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. EDT ...

CLSN BIOQ 0HUZ.L

Read more →
Published at

Sep 17, 2021 3:00 PM

by thestreet.com

positive

positive

Celsion And Hainan Poly Pharm Sign Agreement To Manufacture Celsion's DNA-based Vaccine

E xpands GEN-1 P rogram C ollaboration to Add C linical and C ommercial B atches of I nvestigational V accine LAWRENCEVILLE, N.J. and HAINAN,

CLSN 300630.SZ 0HUZ.L

Read more →
Published at

Sep 17, 2021 3:00 PM

by globenewswire.com

positive

positive

Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion’s DNA-based Vaccine

Expands GEN-1 Program Collaboration to Add Clinical and Commercial Batches of Investigational Vaccine LAWRENCEVILLE, N.J. and HAINAN, China, Sept. 17,...

CLSN 300630.SZ 0HUZ.L

Read more →